Table 1 Demographics, clinical and CT findings of the entire study population*, Group 1 (patients underwent MDCT scan only) and Group 2 (patients also underwent CA).

	Study population*	Group 1	Group 2	p Value
Demographics
Population	132	72	44
Men (%)	111 (84.1)	58 (80.6)	38 (86.4)	0.582
Age mean, years (SD)	60.8 (11.7)	56.2 (13.2)	65.5 (10.8)	0.001
Disease (%)				0.954
Aortic valve insufficiency/stenosis	34 (25.7)	20 (27.8)	9 (20.5)
Mitral valve insufficiency/stenosis	17 (12.9)	9 (12.5)	7 (15.9)
Ascending aorta aneurysm	62 (47.0)	34 (47.2)	20 (45.4)
Aortic dissection type A or B	19 (14.4)	9 (12.5)	8 (18.2)
Co‐morbidities (%)
COPD	7 (5.3)	3 (4.2)	3 (6.8)	0.846
Diabetes	12 (9.1)	6 (8.3)	4 (9.1)	0.842
Hypertension	88 (66.7)	42 (58.3)	30 (68.2)	0.388
Dyslipidosis	37 (28.0)	18 (25.0)	14 (31.8)	0.560
Smoking	47 (35.6)	22 (30.5)	19 (43.2)	0.238
Family history	29 (21.9)	15 (20.8)	10 (22.7)	0.994
EuroSCORE (SD)	6.2 (0.9)	5.8 (0.9)	6.5 (0.8)	0.0022
CT calcium scoring (Agatston score)
Mean Agatston value (SD)	150.3 (192.7)	111.2 (154.7)	214.4 (255.0)
Median (min–max)	52 (0–814)	35.5 (0–579)	67 (0–814)	0.013
CT angiography (quality score)*				0.029
Score 1 (excellent)	47 (35.6)	36 (50%)	11 (25%)
Score 2 (good)	36 (27.3)	19 (26.4%)	17 (38.6%)
Score 3 (moderate)	33 (25.0)	17 (23.6%)	16 (36.4%)
Score 4 (poor)	10 (7.6)	–	–
Score 5 (not assessable)	6 (4.5)	–	–
CT left ventricular function (EF)†
EF >50%	78 (67.2)	51 (70.8)	27 (61.4)	0.395
EF ⩽50%	38 (32.8)	21 (29.2)	17 (38.6)
Mean EF (SD)	55.3 (27.5)	56.5 (29.1)	52.4 (12.4)	0.378

*n = 132 Patients who underwent MDCTA scan (total number of patients = 143). †n = 116 Patients who had an MDCT scan of diagnostic quality.

COPD, chronic obstructive pulmonary disease; EF, ejection fraction.